Well Referenced

Tag: IIEF-5

Extracorporeal Shockwave Therapy Combined with Drug Therapy in Chronic Pelvic Pain Syndrome: A Randomized Clinical Trial

This randomized clinical trial assessed the efficacy of combining extracorporeal shockwave therapy (ESWT) with pharmacotherapy in treating chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Thirty-one male patients were divided into two groups: the intervention group received a combination of an alpha-blocker, anti-inflammatory agent, muscle relaxant, a short course of antibiotics, and

Read More »
June 26, 2025 No Comments

The Effect of Intracavernosal Injection of Stem Cell in the Treatment of Erectile Dysfunction in Diabetic Patients: A Randomized Single-blinded Clinical Trial

This 2021 randomized, single-blind clinical trial evaluated the safety and efficacy of intracavernosal injection of autologous oral mucosa-derived mesenchymal stem cells (MSCs) in 20 diabetic men with erectile dysfunction (ED) unresponsive to standard treatments. Participants were divided into intervention (n=10) and control (n=10) groups. The intervention group received a single

Read More »
June 26, 2025 No Comments

Daily Oral l-Arginine Plus Tadalafil in Diabetic Patients with Erectile Dysfunction: A Double-Blinded, Randomized, Controlled Clinical Trial

This 2019 double-blind, randomized controlled trial evaluated the efficacy of daily oral l-arginine (2.5 g) combined with tadalafil (5 mg) in 108 diabetic men with mild to moderate erectile dysfunction (ED). Over an 8-week period, patients receiving the combination therapy exhibited significant improvements in International Index of Erectile Function-5 (IIEF-5)

Read More »
June 26, 2025 No Comments

Safety and Efficacy of 2 Intracavernous Injections of Allogeneic Wharton’s Jelly-Derived Mesenchymal Stem Cells in Diabetic Patients with Erectile Dysfunction: Phase 1/2 Clinical Trial

This 2021 phase 1/2 clinical trial evaluated the safety and efficacy of two intracavernous injections of allogeneic Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) in 22 diabetic men with refractory erectile dysfunction (ED). The procedure was well-tolerated, with only minimal and transient adverse events such as redness and bruising at the

Read More »
June 26, 2025 No Comments